GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Trillium Therapeutics Inc (NAS:TRIL) » Definitions » PB Ratio

Trillium Therapeutics (Trillium Therapeutics) PB Ratio : 8.51 (As of Apr. 26, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Trillium Therapeutics PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-04-26), Trillium Therapeutics's share price is $18.44. Trillium Therapeutics's Book Value per Share for the quarter that ended in Sep. 2021 was $2.17. Hence, Trillium Therapeutics's PB Ratio of today is 8.51.

The historical rank and industry rank for Trillium Therapeutics's PB Ratio or its related term are showing as below:

TRIL' s PB Ratio Range Over the Past 10 Years
Min: 2.48   Med: 5.65   Max: 18.96
Current: 8.42

During the past 13 years, Trillium Therapeutics's highest PB Ratio was 18.96. The lowest was 2.48. And the median was 5.65.

TRIL's PB Ratio is not ranked
in the Biotechnology industry.
Industry Median: 2.385 vs TRIL: 8.42

During the past 12 months, Trillium Therapeutics's average Book Value Per Share Growth Rate was 26.40% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 19.10% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Trillium Therapeutics was 104.00% per year. The lowest was -42.20% per year. And the median was -7.50% per year.

Back to Basics: PB Ratio


Trillium Therapeutics PB Ratio Historical Data

The historical data trend for Trillium Therapeutics's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Trillium Therapeutics PB Ratio Chart

Trillium Therapeutics Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.29 4.77 - - 5.75

Trillium Therapeutics Quarterly Data
Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.65 5.75 4.30 4.17 8.11

Competitive Comparison of Trillium Therapeutics's PB Ratio

For the Biotechnology subindustry, Trillium Therapeutics's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Trillium Therapeutics's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Trillium Therapeutics's PB Ratio distribution charts can be found below:

* The bar in red indicates where Trillium Therapeutics's PB Ratio falls into.



Trillium Therapeutics PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Trillium Therapeutics's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Sep. 2021)
=18.44/2.166
=8.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Trillium Therapeutics  (NAS:TRIL) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Trillium Therapeutics PB Ratio Related Terms

Thank you for viewing the detailed overview of Trillium Therapeutics's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Trillium Therapeutics (Trillium Therapeutics) Business Description

Traded in Other Exchanges
N/A
Address
100 CambridgePark Drive, Suite 510, Cambridge, MA, USA, 02140
Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.

Trillium Therapeutics (Trillium Therapeutics) Headlines

From GuruFocus

Trillium Securityholders Approve Acquisition by Pfizer

By GlobeNewswire GlobeNewswire 10-26-2021

Trillium Therapeutics Joins Russell 2000� and 3000� Indices

By GlobeNewswire GlobeNewswire 06-26-2021